|
|
S&P 500
7,440.43
+86.41 (+1.18%)
|
|
Dow Jones
52,182.74
+306.63 (+0.59%)
|
|
NASDAQ
25,820.14
+522.53 (+2.07%)
|
|
Market close: June 29, 2026
|
|
|
Stock Market Today
|
Dow, S&P 500, Nasdaq futures steady after
record-setting session
US stock futures took a breather on Tuesday after a
record-setting start to the week, as investors assessed
concerns around a potential oil glut and the dollar's
growing strength.
Dow Jones Industrial Average futures hovered above the
flat line, after the blue-chip benchmark closed above
52,000 for the first time on Monday.
Contracts on the S&P 500 and the Nasdaq 100 were also
little changed after a rally in tech stocks fueled sharp
gains.
Investors are heading into the last trading day of the
second quarter and first half of 2026 buoyed by a
Supreme Court ruling that left Federal Reserve
independence intact, for now, and by the prospect of
potential US-Iran peace talks in Qatar starting Tuesday.
At the same time, oil flows through the Strait of Hormuz
are recovering faster than expected, prompting a shift
from fears of crude shortages to warnings of a looming
glut.
Oil prices continued to fall, poised for a quarterly
drop with Brent futures trading below $74 a barrel and
WTI futures below $71.
Yahoo
Finance
reports.
|
|
|
Image source: Pexels
|
|
|
EdgeUp
|
🛰️ AST SpaceMobile shares surge, gain almost $6
billion
on Japan subsidy report
AST SpaceMobile, Inc. pushed higher in early trading
Tuesday, gaining more market cap in one session than the
total size of the Japan subsidy that sparked the run.
The satellite-to-phone stock finished Monday at $86.77,
a jump of 21.44%.
Google Finance showed another 0.83% gain to $87.49 in
premarket.
Nasdaq’s premarket window is from 4:00 a.m. to 9:30 a.m.
Eastern.
AST closed with a market cap of $33.68 billion,
according to Google Finance.
Shares jumped 21.44%, tacking on roughly $5.95 billion
from the last close.
That’s about 6.4 times the $926 million Japanese subsidy
pool cited, and market cap is around 36 times that
figure.
The math is rough—market cap is from the close and
doesn’t use a fully diluted model.
TechStock²
reports.
|
|
🔒 Intrusion Announces Acquisition of VigilAigent.
Stock soars in pre-market
Intrusion Inc., a leader in cyberattack prevention
solutions, today announced it has completed the
acquisition of VigilAigent, a cybersecurity managed
security service provider, from Tego Cyber Inc.
The acquisition will accelerate Intrusion's growth
strategy by adding approximately $3.5 million in annual
recurring revenue from a diversified base of multi-year
customer contracts, an established reseller network of
more than 80 partners, and an installed base of
approximately 1,000 customers, extending Intrusion's
commercial reach from day one. Access
Newswire
reports.
|
|
⚙️ Applied Materials shares surge $54 billion,
buyback effect now smaller
Applied Materials heads into Tuesday with a buyback
issue of its own making.
After shares jumped 10.82% Monday, each dollar left in
its repurchase plan now has less impact on earnings per
share.
The chip equipment stock ended at $694.64, gaining
$67.80 on the day after reaching an intraday high of
$708.99.
Around 14.17 million shares changed hands, which is
roughly 1.7 times its 65-day average volume.
MarketWatch posted an after-hours quote of $704.01 at
7:59 p.m. EDT.
TechStock²
reports.
|
|
🩺 Cuprina Receives U.S. FDA 510(k) Clearance for
MEDIFLY Maggots. Stock rises 20% in pre-market.
Cuprina Holdings (Cayman) Limited, a biomedical company
developing and marketing products for the chronic
wounds, infertility, medical waste recycling, and
cosmeceuticals sectors, today announced that an
indirectly wholly owned subsidiary of the company,
Cuprina Pte. Ltd., has received 510(k) clearance from
the U.S. Food and Drug Administration for MEDIFLY
Maggots, its medical-grade Lucilia cuprina larvae used
in maggot debridement therapy. To the company's
knowledge, MEDIFLY Maggots is the first maggot
debridement product to receive U.S. FDA 510(k) clearance
using the Lucilia cuprina species.
MEDIFLY Maggots is cleared for the debridement of
non-healing necrotic skin and soft tissue wounds,
including pressure ulcers, neuropathic foot ulcers, and
non-healing traumatic or post-surgical wounds.
The prescription product consists of medical-grade fly
larvae applied to a wound under the supervision of
trained healthcare professionals to remove dead and
infected tissue and support the body's natural healing
process.
Globe
Newswire
reports.
|
|
|
Don’t miss TradeZero America’s Summer
Promo
|
|
The PDT rule is gone on June 4. To celebrate –
TradeZero America gives you:
- 50% off options contract fees — $0.21 per
contract (down
from $0.42)
- 15% off every eligible locate fee
Automatically applied from June 4 through September
4,
2026. No sign-up code needed. Dormant accounts that
reactivate during the period also qualify. T&Cs
apply.
Active trading and day trading involve substantial
risk
and are not suitable for all investors. Investors
may
lose more than their initial investment.
|
See the full
summer promotion
|
|
|
Join Us Live This Week
|
|
Sharpen your trading skills with free trading education
in our weekly TradeZero Live Podcasts.
Today, June 30 | 11:00 AM ET
How To Develop a Consistent Trading Process with Bob
Iaccino
|
Save Your
Seat
|
|
|
Tech Stumbled, the Market Didn't — Now What?
|
with Richie Naso, a
Wall Street veteran of over 40 years and former member
of the NYSE.
|
This past week put a question to the test that's been
nagging investors for years: what happens if the tech
stocks dominating this market actually fall hard?
The answer, so far, is encouraging — the Mag 7 ETF
posted its worst week in over a year and the Nasdaq
dropped roughly 4.6%, yet the Dow still finished higher
and the equal-weighted S&P 500 outperformed its
cap-weighted counterpart by the widest margin since
2020, as financials, industrials, and small caps stepped
up to fill the gap.
Beneath the surface, the picture looks healthier than
the headlines suggest: market breadth has improved,
Treasury yields have stayed steady, and credit markets
continue to behave constructively.
That said, I'm not popping champagne just yet — Friday's
price action should have produced a stronger bounce
given the amount of short covering and bottom-fishing
that took place, and the market's inability to deliver a
more convincing rally leaves me cautious.
The market feels coiled for a meaningful move; if tech
regains its footing, this rally has room to run, but if
not, the rotation into financials, industrials, and
small caps will need to prove it can carry the load on
its own. I remain watchful here.
|
|
|
Top 5 Movers in Early Pre-Market
|
(All pricing and percent gains are based on Early
Pre-Market from 4:00 AM to 7:00 AM ET)
Stock Analysis reports.
|
1) JEM: 707 Cayman
Holdings Limited
Total gain: +194.44%
|
|
2) ABVX: ABIVAX Société
Anonyme
Total gain: +35.67%
|
|
3) AVAV: AeroVironment,
Inc.
Total gain: +33.68%
|
|
4) CUPR: Cuprina Holdings
(Cayman) Limited
Total gain: +23.99%
|
|
5) PAVS: Paranovus
Entertainment Technology Ltd.
Total gain: +23.90%
|
|
|
Today’s Economic Dates
|
|
Time (ET)
|
Report
|
Period
|
|
9:00 AM
|
S&P Cotality Case-Shiller Home Px Index
|
Apr.
|
|
9:45 AM
|
Chicago Business Barometer - ISM-Chicago
Business Survey - Chicago PMI
|
Jun.
|
|
10:00 AM
|
Conference Bd - Consumer Confidence
|
Jun.
|
|
View
more
|
|
|
Yesterday's Biggest Movers
|
|
The closing price of the top three market percent
gainers trading near or above $3 on
June 29.
|
All pricing and percent gains are based on regular
market trading hours from 9:30 AM to
4:00 PM ET
Stock Analysis reports.
|
1) HCWB: HCW
Biologics Inc.
Total gain: +410.29%
The company announced that its Board of Directors
has approved a 1-for-6
reverse stock split of the Company's common stock,
par value $0.0001
(“Common Stock”), which will be effective at 12:01
a.m. Eastern Time on June
30, 2026. The Company's Common Stock will be traded
on The Nasdaq
Capital Market on a reverse split-adjusted basis
beginning on June 30, 2026,
under the Company's existing trading symbol “HCWB.”
Globe
Newswire
reports.
|
|
2) UPC:
Universe Pharmaceuticals INC
Total gain: +311.49%
The company announced that the company has entered
into a share purchase
agreement to acquire 100% of the issued shares of
Best Praise International
Limited (“Best Praise”), a company that holds five
patents in China with
potential applications in pharmaceutical
development, for a total purchase price
of US$10,751,000, payable in the form of 4,376,552
Class A ordinary shares of
the Company. Globe
Newswire
reports.
|
|
3) DCOY: Decoy
Therapeutics Inc.
Total gain: +73.73%
The company announced that it has entered into a
securities purchase
agreement with a single healthcare focused
institutional investor for a private
investment in public equity financing (the "PIPE"),
which is expected to provide
approximately $3.5 million in gross proceeds at
closing, before deducting
placement agent's fees and other financing expenses
payable by the
Company. The Company intends to use the net proceeds
to advance its lead
asset into clinical trials. PR
Newswire
reports.
|
|
|
Refer a Friend & Earn Together
|
|
Did you know that it pays to invite your friends to
TradeZero?
|
|
When they fund a new account with us, you’ll both
receive $100 USD. T&Cs apply.
|
|
Learn
more
|
|
|
Today’s Notable Earnings
|
Estimate and Actual numbers represent Earnings Per Share in US
Dollars
|
|
|
STZ
Constellation Brands
Q1 2027
|
After Market Close
Estimate: 3.210
Actual: N/A
|
|
|
|
NKE
Nike
Q4 2026
|
After Market Close
Estimate: 0.120
Actual: N/A
|
|
|
|
PRGS
Progress Software
Q2 2026
|
After Market Close
Estimate: 1.420
Actual: N/A
|
|
View more
|
|
Enjoying the DailyEdge?
|
|
Recommend our 5-minute daily digest to a friend by
sharing
this
link.
|
|
|
Parting Thoughts
|
|
“Victory belongs to the most persevering.”
|
|
– Napoleon Bonaparte
|
|
Sourced in: Napoleon quotations
— GoodReads.
|
|
|
|
TradeZero America, Inc., member of FINRA and
SIPC. Investing involves risk, including the
possible loss of principal.
The information in this newsletter
summarizes the latest market activity and
related news and are provided for
educational purposes only. Any trading
symbols displayed are for illustrative
purposes only and do not constitute a
recommendation by TradeZero to buy, sell, or
hold any investment. This material is not
intended to provide investment advice or to
take into account any individual’s financial
condition, investment objectives, or
requirements.
Stocks experiencing significant price
volatility may involve substantial risk.
Past performance is no guarantee of future
results.
Options trading is not suitable for all
investors as it can involve risk that may
expose investors to significant losses.
Please read the Characteristics and Risks of
Standardized Options, also known as the
Options Disclosure Document (ODD) at OCC.
Any trading strategies discussed are for
educational purposes only and should not be
construed as investment advice or a
recommendation.
Certain information herein has been obtained
from third-party sources believed to be
reliable; however, its accuracy or
completeness cannot be guaranteed. The views
and opinions expressed are those of the
author and do not necessarily reflect the
views or opinions of TradeZero, its
affiliates, or employees.
If you have any specific questions about
TradeZero's brokerage services, please reach
out to the TradeZero Broker Dealer servicing
your jurisdiction.
Copyright © TradeZero 2026. All rights
reserved.
|
|
|
|
